CareDx Inc.

NAS: CDNA

GO
/marketstate/country/us

Market open

 --Real time quotes

Aug 13, 2020, 11:28 a.m.

/zigman2/quotes/200138382/composite

$

32.06

Change

+0.73 +2.33%

Volume

Volume 252,850

Real time quotes

/zigman2/quotes/200138382/composite

Previous close

$ 31.33

$ 32.06

Change

+0.73 +2.33%

Day low

Day high

$31.08

$32.22

Open

52 week low

52 week high

$13.04

$37.55

Open

Company Description

CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Valuation

Price to Sales Ratio

7.16

Price to Book Ratio

9.26

Enterprise Value to Sales

6.88

Total Debt to Enterprise Value

0.00

Efficiency

Revenue/Employee

329,192.00

Income Per Employee

-56,912.00

Receivables Turnover

7.52

Total Asset Turnover

0.87

Liquidity

Current Ratio

2.07

Quick Ratio

1.89

Cash Ratio

1.10

Profitability

Gross Margin

63.20

Operating Margin

-18.83

Pretax Margin

-18.85

Net Margin

-17.29

Return on Assets

-15.02

Return on Equity

-22.54

Return on Total Capital

-24.10

Return on Invested Capital

-22.50

Capital Structure

Total Debt to Total Equity

3.33

Total Debt to Total Capital

3.22

Total Debt to Total Assets

2.08

Long-Term Debt to Equity

0.07

Long-Term Debt to Total Capital

0.07

Officers and Executives

Name Age Officer Since Title
Dr. Peter K. Maag 52 2012 Chief Executive Officer & Director
Dr. Reginald Seeto 47 2018 President & Chief Business Officer
Mr. Paul Ciccolella - 2018 Senior Vice President-Global Operations
Mr. Michael Bell 50 2017 Chief Financial & Principal Accounting Officer
Dr. Amitabh Shukla - 2019 Senior Vice President-Technology

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/06/2020 Reginald Seeto
See Remarks
413   Derivative/Non-derivative trans. at $34.65 per share. 14,310
08/06/2020 Michael Bell
Chief Financial Officer
619   Derivative/Non-derivative trans. at $34.65 per share. 21,448
08/06/2020 Sasha King
Chief Commercial Officer
309   Derivative/Non-derivative trans. at $34.65 per share. 10,706
08/05/2020 Peter K. Maag
Chief Executive Officer; Director
6,600   Disposition at $37.11 per share. 244,926
08/05/2020 Peter K. Maag
Chief Executive Officer; Director
5,808   Disposition at $36.59 per share. 212,514
08/05/2020 Peter K. Maag
Chief Executive Officer; Director
600   Disposition at $34.86 per share. 20,916
08/05/2020 Peter K. Maag
Chief Executive Officer; Director
9,848   Derivative/Non-derivative trans. at $5.27 per share. 51,898
08/05/2020 Peter K. Maag
Chief Executive Officer; Director
3,160   Derivative/Non-derivative trans. at $5.49 per share. 17,348
07/06/2020 Peter K. Maag
Chief Executive Officer; Director
10,000   Disposition at $34.21 per share. 342,100
07/06/2020 Peter K. Maag
Chief Executive Officer; Director
5,240   Derivative/Non-derivative trans. at $5.27 per share. 27,614
07/06/2020 Peter K. Maag
Chief Executive Officer; Director
1,983   Derivative/Non-derivative trans. at $2.3 per share. 4,560
07/06/2020 Peter K. Maag
Chief Executive Officer; Director
2,777   Derivative/Non-derivative trans. at $2.8 per share. 7,775
07/06/2020 Peter K. Maag
Chief Executive Officer; Director
40,000   Award at $0 per share. 0
07/06/2020 Reginald Seeto
See Remarks
40,000   Award at $0 per share. 0
07/06/2020 Michael Bell
Chief Financial Officer
40,000   Award at $0 per share. 0
07/06/2020 Sasha King
Chief Commercial Officer
5,000   Award at $0 per share. 0
07/01/2020 George W. Bickerstaff
Director
527   Award at $0 per share. 0
07/01/2020 Michael D. Goldberg
Director
1,282   Award at $0 per share. 0
07/01/2020 Ralph D. Snyderman
Director
439   Award at $0 per share. 0
07/01/2020 Christine M. Cournoyer
Director
483   Award at $0 per share. 0
06/30/2020 Peter K. Maag
Chief Executive Officer; Director
18,182   Disposition at $35.07 per share. 637,642
06/30/2020 Peter K. Maag
Chief Executive Officer; Director
9,267   Derivative/Non-derivative trans. at $2.3 per share. 21,314
06/18/2020 George W. Bickerstaff
Director
3,190   Award at $0 per share. 0
06/18/2020 Michael D. Goldberg
Director
3,190   Award at $0 per share. 0
06/18/2020 Ralph D. Snyderman
Director
3,190   Award at $0 per share. 0
06/18/2020 Fred E. Cohen
Director
3,190   Award at $0 per share. 0
06/18/2020 William A. Hagstrom
Director
3,190   Award at $0 per share. 0
06/18/2020 Christine M. Cournoyer
Director
3,190   Award at $0 per share. 0
06/18/2020 Grace E. Colón
Director
3,190   Award at $0 per share. 0
06/09/2020 Peter K. Maag
Chief Executive Officer; Director
1,818   Disposition at $35 per share. 63,630
06/05/2020 Peter K. Maag
Chief Executive Officer; Director
500   Disposition at $33.06 per share. 16,530
06/05/2020 Peter K. Maag
Chief Executive Officer; Director
49,500   Disposition at $32.58 per share. 1,612,710
06/01/2020 Peter K. Maag
Chief Executive Officer; Director
18,592   Derivative/Non-derivative trans. at $32.82 per share. 610,189
06/01/2020 Michael Bell
Chief Financial Officer
6,197   Derivative/Non-derivative trans. at $32.82 per share. 203,385
06/01/2020 Sasha King
Chief Commercial Officer
4,843   Derivative/Non-derivative trans. at $32.82 per share. 158,947
06/01/2020 Sasha King
Chief Commercial Officer
25,402   Disposition at $33.1 per share. 840,806
06/01/2020 Sasha King
Chief Commercial Officer
25,402   Disposition at $33.1 per share. 840,806
06/01/2020 Sasha King
Chief Commercial Officer
5,833   Derivative/Non-derivative trans. at $5.9 per share. 34,414
06/01/2020 Sasha King
Chief Commercial Officer
1,111   Derivative/Non-derivative trans. at $2.8 per share. 3,110
06/01/2020 Sasha King
Chief Commercial Officer
4,000   Derivative/Non-derivative trans. at $27.17 per share. 108,680
06/01/2020 Sasha King
Chief Commercial Officer
1,458   Derivative/Non-derivative trans. at $1.07 per share. 1,560
06/01/2020 Sasha King
Chief Commercial Officer
8,333   Derivative/Non-derivative trans. at $12.24 per share. 101,995
06/01/2020 Sasha King
Chief Commercial Officer
1,750   Derivative/Non-derivative trans. at $1 per share. 1,750
06/01/2020 Sasha King
Chief Commercial Officer
2,917   Derivative/Non-derivative trans. at $6.31 per share. 18,406
05/19/2020 Peter K. Maag
Chief Executive Officer; Director
30,000   Disposition at $32.24 per share. 967,200
/news/latest/company/us/cdna

MarketWatch News on CDNA

  1. Charting a bull-trend pullback, S&P 500 nails first support (2,873)

    11:28 a.m. June 13, 2019

    - Michael Ashbaugh

  2. CareDx stock price target raised to $46 from $38 at Raymond James

    9:20 a.m. March 22, 2019

    - Tomi Kilgore

  3. Harry Boxer’s four stocks to watch this week

    2:46 p.m. Nov. 1, 2018

    - Harry Boxer

  4. CareDX stock soars nearly 20% after earnings

    7:40 p.m. Aug. 9, 2018

    - Max A. Cherney

  5. CareDx stock price target raised to $10 from $8 at Raymond James

    8:50 a.m. March 23, 2018

    - Tomi Kilgore

  6. Lowe’s Is Adding Three New Directors to Board

    12:15 a.m. Jan. 27, 2018

    - Barron's Online

  7. Activist Starboard Value Squares Up Its Position in Monotype

    12:55 a.m. Oct. 14, 2017

    - Barron's Online

  8. CareDx upgraded to outperform from market perform at Raymond James

    7:58 a.m. Sept. 27, 2017

    - Tomi Kilgore

  9. Almost half of venture-backed IPOs this year are losers

    6:00 a.m. Oct. 3, 2014

    - Philip van Doorn

/news/nonmarketwatch/company/us/cdna

Other News on CDNA

  1. CareDx, Inc 2020 Q2 - Results - Earnings Call Presentation

    4:00 p.m. Aug. 7, 2020

    - Seeking Alpha

  2. 10-Q: CAREDX, INC.

    5:10 p.m. Aug. 4, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  3. Notable earnings after Tuesday's close

    5:35 p.m. Aug. 3, 2020

    - Seeking Alpha

  4. CareDx Q2 2020 Earnings Preview

    5:35 p.m. Aug. 3, 2020

    - Seeking Alpha

  5. CareDx (CDNA) Investor Presentation - Slideshow

    11:18 a.m. May 30, 2020

    - Seeking Alpha

  6. CareDx, Inc 2020 Q1 - Results - Earnings Call Presentation

    2:08 p.m. May 1, 2020

    - Seeking Alpha

  7. CareDx (CDNA) Reports Break-Even Earnings for Q1

    8:15 p.m. April 30, 2020

    - Zacks.com

  8. 10-Q: CAREDX, INC.

    5:23 p.m. April 30, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  9. Notable earnings after Thursday's close

    5:35 p.m. April 29, 2020

    - Seeking Alpha

  10. CareDx Q1 2020 Earnings Preview

    5:35 p.m. April 29, 2020

    - Seeking Alpha

  11. CareDx: A Robust Transplant Diagnostics Pick For 2020

    4:47 p.m. April 23, 2020

    - Seeking Alpha

  12. CareDx Inc (CDNA) Investor Presentation - Slideshow

    3:12 p.m. March 5, 2020

    - Seeking Alpha

  13. Loading more headlines...

At a Glance

CareDx, Inc.

1 Tower Place

South San Francisco, California 94080

Phone

1 4152872300

Industry

Healthcare Provision

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

$127.07M

Net Income

$-21.97M

2019 Sales Growth

66.0%

Employees

386.00

/news/pressrelease/company/us/cdna

Press Releases on CDNA

  1. CareDx Reports Second Quarter 2020 Results

    4:06 p.m. Aug. 4, 2020

    - GlobeNewswire

  2. CareDx Reports Second Quarter 2020 Results

    4:05 p.m. Aug. 4, 2020

    - GlobeNewswire

  3. CareDx to Report Second Quarter 2020 Financial Results

    4:06 p.m. July 16, 2020

    - GlobeNewswire

  4. CareDx to Report Second Quarter 2020 Financial Results

    4:05 p.m. July 16, 2020

    - GlobeNewswire

  5. CareDx Announces Closing of Public Offering of Common Stock

    4:05 p.m. June 15, 2020

    - GlobeNewswire

  6. CareDx Announces Closing of Public Offering of Common Stock

    4:05 p.m. June 15, 2020

    - GlobeNewswire

  7. Loading more headlines...
Link to MarketWatch's Slice.